Rocking Motion: Physiologic Effect on the Surgical Stress Response
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gastrointestinal Cancer
Related studies linked through entity extraction aliases.
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of 3 Day Preoperative Immunonutrition in Well-nourished Patients With Gastrointestinal (GI) Cancer Undergoing Surgery
- Status
- TERMINATED
- Phase
- NA
Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
- Status
- UNKNOWN
- Phase
- N/A
Screening to Predict Weight Loss in Patients With Cancer
- Status
- UNKNOWN
- Phase
- NA
Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
- Status
- TERMINATED
- Phase
- N/A
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3